Tretinoin (INN) (retinoic acid and its salts)
Tretinoin (INN) (retinoic acid and its salts) is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties

Retinoic Acid
All-trans-retinoic acid is a retinoic acid in which all four exocyclic double bonds have E- (trans-) geometry. It has a role as an antioxidant, an antineoplastic agent, a keratolytic drug, a signalling molecule, a retinoid X receptor agonist, an anti-inflammatory agent, a retinoic acid receptor agonist, an AP-1 antagonist and a human metabolite. It is a vitamin A and a retinoic acid. It is a conjugate acid of an all-trans-retinoate. — ChEBI
- IUPAC name
- (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
- Molecular formula
- C20H28O2
- Molecular weight
- 300.4 g/mol
- Exact mass
- 300.208930132 Da
- XLogP3
- 6.3
- Topological polar surface area
- 37.3 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 2
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Tretinoin (INN) (retinoic acid and its salts)
Regulatory information
Identified ingredients
Key data
Inventory links for Tretinoin (INN) (retinoic acid and its salts)
Related records for Tretinoin (INN) (retinoic acid and its salts)
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
Phytolacca spp. and their preparations
1-Methoxy-2,4-diaminobenzene (2,4-Diaminoanisole - CI 76050) and its salts
3,4',5-Tribromosalicylanilide (Tribromsalan (INN))
1-Methoxy-2,5-diaminobenzene (2,5-Diaminoanisole) and its salts
6-(Piperidinyl)-2,4-pyrimidinediamine-3-oxide (Minoxidil (INN)) and its salts
2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane (Hexachlorophene (INN))
Colouring agent CI 26105 (Solvent Red 24)
captan (ISO); 1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide
4-[[4,4'-bis(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride […
Pyrithione sodium (INNM) (2)
Amyl 4-dimethylaminobenzoate, mixed isomers (Padimate A (INN))
What Annex II means for Tretinoin (INN) (retinoic acid and its salts)
Tretinoin (INN) (retinoic acid and its salts) is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
This record is linked to 3 CosIng inventory ingredients for name and identifier cross-reference. The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
Frequently asked questions
Source note for Annex II record Tretinoin (INN) (retinoic acid and its salts)
This page summarizes one Annex II record for Tretinoin (INN) (retinoic acid and its salts) from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Tretinoin (INN) (retinoic acid and its salts), but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Tretinoin (INN) (retinoic acid and its salts) and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Tretinoin (INN) (retinoic acid and its salts) side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II